ATE493403T1 - Kinaseinhibitoren - Google Patents

Kinaseinhibitoren

Info

Publication number: ATE493403T1
Authority: AT; Austria
Prior art keywords: kinase inhibitors; kinase; inhibitors
Prior art date: 2005-10-28

Application number

AT06826650T

Other languages

English (en)

Inventor

Jolie Bastian

De Blas Jesus Blas

Dios Alfonso De

Kevin Hudziak

Tiechao Li

De Uralde-Garmendia Beatriz Lapez

Mary Mader

Michael Myers

Mark Pobanz

Chuan Shih

Boyu Zhong

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-28

Filing date

2006-10-25

Publication date

2011-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43298635&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE493403(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-10-25 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2011-01-15 Application granted granted Critical

2011-01-15 Publication of ATE493403T1 publication Critical patent/ATE493403T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT06826650T 2005-10-28 2006-10-25 Kinaseinhibitoren ATE493403T1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US73160405P	2005-10-28	2005-10-28
EP06380151		2006-06-02
US82196306P	2006-08-10	2006-08-10
PCT/US2006/041644 WO2007053394A1 (en)	2005-10-28	2006-10-25	Kinase inhibitors

Publications (1)

Publication Number	Publication Date
ATE493403T1 true ATE493403T1 (de)	2011-01-15

Family

ID=43298635

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06826650T ATE493403T1 (de)	2005-10-28	2006-10-25	Kinaseinhibitoren

Country Status (19)

Country	Link
US (1)	US7652015B2 (de)
EP (1)	EP1943243B1 (de)
KR (1)	KR101004156B1 (de)
AR (1)	AR056582A1 (de)
AT (1)	ATE493403T1 (de)
AU (1)	AU2006309044B2 (de)
BR (1)	BRPI0616901A2 (de)
CA (1)	CA2627673A1 (de)
DK (1)	DK1943243T3 (de)
DO (1)	DOP2006000234A (de)
EA (1)	EA015189B1 (de)
PE (1)	PE20070795A1 (de)
PL (1)	PL1943243T3 (de)
PT (1)	PT1943243E (de)
RS (1)	RS51949B (de)
SI (1)	SI1943243T1 (de)
TN (1)	TNSN08191A1 (de)
TW (1)	TWI325423B (de)
WO (1)	WO2007053394A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0905955D0 (en)	2009-04-06	2009-05-20	Respivert Ltd	Novel compounds
EP2556068B1 (de)	2010-04-08	2019-01-23	Respivert Limited	P38-map-kinasehemmer
EP2582700B1 (de)	2010-06-17	2016-11-02	Respivert Limited	Formulierungen für die atemwege enthaltend inhibitoren von p38 mapk
AU2012289254A1 (en)	2011-07-26	2014-03-13	Grünenthal GmbH	Substituted bicyclic aromatic carboxamide and urea derivatives as vanilloid receptor ligands
US9783556B2 (en)	2012-08-29	2017-10-10	Respivert Limited	Kinase inhibitors
WO2014033447A2 (en)	2012-08-29	2014-03-06	Respivert Limited	Kinase inhibitors
WO2014033446A1 (en)	2012-08-29	2014-03-06	Respivert Limited	Kinase inhibitors
US9732063B2 (en)	2012-11-16	2017-08-15	Respivert Limited	Kinase inhibitors
US9771353B2 (en)	2013-04-02	2017-09-26	Topivert Pharma Limited	Kinase inhibitors based upon N-alkyl pyrazoles
KR102283883B1 (ko)	2013-04-02	2021-07-29	옥슬러 액퀴지션즈 리미티드	키나제 저해제
WO2015092423A1 (en)	2013-12-20	2015-06-25	Respivert Limited	Urea derivatives useful as kinase inhibitors
SI3113772T1 (sl)	2014-03-07	2021-01-29	Biocryst Pharmaceuticals, Inc.	S trifluorometilom substituirani pirazoli kot inhibitorji plazemskih kalikreinov pri človeku
MA40775A (fr)	2014-10-01	2017-08-08	Respivert Ltd	Dérivé d'acide 4-(4-(4-phényluréido-naphtalén -1-yl) oxy-pyridin-2-yl) amino-benzoïque utilisé en tant qu'inhibiteur de la kinase p38
EP3440073B1 (de)	2016-04-06	2022-06-08	Oxular Acquisitions Limited	Kinaseinhibitoren
CA3077499C (en)	2017-10-05	2021-09-21	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
US10342786B2 (en)	2017-10-05	2019-07-09	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
LT3700902T (lt)	2017-10-27	2023-06-26	Boehringer Ingelheim International Gmbh	Trpc6 inhibitoriai
JP2023537963A (ja)	2020-08-13	2023-09-06	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	統合失調症に伴う認知機能障害に対する処置法
US12275722B2 (en)	2020-10-13	2025-04-15	Boehringer Ingelheim International Gmbh	Process of reworking a crystalline form of a glycine transport inhibitor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69836563T2 (de) *	1997-12-22	2007-05-16	Bayer Pharmaceuticals Corp., West Haven	INHIBIERUNG DER p38 KINASE-AKTIVITÄT DURCH DIE VERWENDUNG VON ARYL- UND HETEROARYL-SUBSTITUIERTEN HARNSTOFFEN
SI1761520T1 (sl) *	2004-06-23	2008-10-31	Lilly Co Eli	Inhibitorji kinaze

2006
- 2006-10-20 TW TW095138670A patent/TWI325423B/zh not_active IP Right Cessation
- 2006-10-20 AR ARP060104595A patent/AR056582A1/es unknown
- 2006-10-20 DO DO2006000234A patent/DOP2006000234A/es unknown
- 2006-10-20 PE PE2006001275A patent/PE20070795A1/es not_active Application Discontinuation
- 2006-10-25 SI SI200630950T patent/SI1943243T1/sl unknown
- 2006-10-25 EA EA200801199A patent/EA015189B1/ru not_active IP Right Cessation
- 2006-10-25 AU AU2006309044A patent/AU2006309044B2/en not_active Expired - Fee Related
- 2006-10-25 RS RS20110112A patent/RS51949B/en unknown
- 2006-10-25 CA CA002627673A patent/CA2627673A1/en not_active Abandoned
- 2006-10-25 BR BRPI0616901-5A patent/BRPI0616901A2/pt not_active IP Right Cessation
- 2006-10-25 PL PL06826650T patent/PL1943243T3/pl unknown
- 2006-10-25 WO PCT/US2006/041644 patent/WO2007053394A1/en active Application Filing
- 2006-10-25 KR KR1020087010062A patent/KR101004156B1/ko not_active Expired - Fee Related
- 2006-10-25 PT PT06826650T patent/PT1943243E/pt unknown
- 2006-10-25 EP EP06826650A patent/EP1943243B1/de active Active
- 2006-10-25 AT AT06826650T patent/ATE493403T1/de active
- 2006-10-25 DK DK06826650.1T patent/DK1943243T3/da active
- 2006-10-25 US US12/088,526 patent/US7652015B2/en not_active Expired - Fee Related
2008
- 2008-04-25 TN TNP2008000191A patent/TNSN08191A1/en unknown

Also Published As

Publication number	Publication date
SI1943243T1 (sl)	2011-04-29
RS51949B (en)	2012-02-29
CA2627673A1 (en)	2007-05-10
PT1943243E (pt)	2011-01-11
WO2007053394A1 (en)	2007-05-10
EP1943243A1 (de)	2008-07-16
TW200800184A (en)	2008-01-01
EA200801199A1 (ru)	2008-08-29
US20080269244A1 (en)	2008-10-30
PL1943243T3 (pl)	2011-05-31
AU2006309044B2 (en)	2011-10-13
DK1943243T3 (da)	2011-03-07
EP1943243B1 (de)	2010-12-29
KR20080053394A (ko)	2008-06-12
US7652015B2 (en)	2010-01-26
EA015189B1 (ru)	2011-06-30
TNSN08191A1 (en)	2009-10-30
BRPI0616901A2 (pt)	2011-07-05
PE20070795A1 (es)	2007-08-24
AU2006309044A1 (en)	2007-05-10
KR101004156B1 (ko)	2010-12-27
TWI325423B (en)	2010-06-01
DOP2006000234A (es)	2007-05-31
AR056582A1 (es)	2007-10-10

Publication	Publication Date	Title
CY2021013I1 (el)	2021-10-15	Δι-αρυλ μετα-πυριμιδινο αναστολεις κινασων
DK1943243T3 (da)	2011-03-07	Kinase-inhibitorer
CY2017012I2 (el)	2017-11-14	Αναστολεις κινασης τυροσινης bruton
DK1979356T3 (da)	2013-11-18	Carbonylaminopyrrolopyrazoler, kraftige kinaseinhibitorer
DK1704145T3 (da)	2012-09-24	Selektive kinaseinhibitorer
BRPI0811212A2 (pt)	2014-10-29	Inibidores de p70 quinase
DK1926722T3 (da)	2011-12-19	Substituerede benzimidazoler som kinaseinhibitorer
EP1893607A4 (de)	2010-07-21	Checkpoint-kinasehemmer
NO20082517L (no)	2008-07-18	Aminopyrimidiner anvendelige som kinaseinhibitorer
BRPI0716781A2 (pt)	2014-11-18	Inibidores da quinase
IL190078A0 (en)	2008-08-07	Kinase inhibitors
ATE520671T1 (de)	2011-09-15	Pyrimidin-harnstoff-derivate als kinase-hemmer
DK2041138T3 (da)	2014-08-11	Pyrroltriazinkinase-inhibitorer
DK2099447T3 (da)	2013-02-18	Imidazotriaziner og imidazopyrimidiner som kinaseinhibitorer
DK1940839T3 (da)	2013-10-14	Pyridopyrimidione Inhibitors of P13Ka
DK2024375T3 (da)	2011-06-27	Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere
DK1934236T3 (da)	2013-02-25	Heterobifunktionelle pan-selektininhibitorer
DE602007008837D1 (de)	2010-10-14	Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
ATE530545T1 (de)	2011-11-15	Als kinaseinhibitoren geeignete pyrazolylaminopyridinderivate
DK2035385T3 (da)	2010-03-22	Inhibitorer af akt (proteinkinase B)
EP2032141A4 (de)	2009-12-30	Januskinase-hemmer
DK2066662T3 (da)	2013-01-07	Serinhydrolaseinhibitorer
ATE520664T1 (de)	2011-09-15	Tyrosinkinase-hemmer
ATE472532T1 (de)	2010-07-15	Oxindole als kinaseinhibitoren
ATE418545T1 (de)	2009-01-15	Nnrt-inhibitoren

Legal Events

Date	Code	Title	Description
2011-07-15	UEP	Publication of translation of european patent specification	Ref document number: 1943243 Country of ref document: EP

Date

Code

Title

Description

2011-07-15

UEP

Publication of translation of european patent specification

Ref document number: 1943243

Country of ref document: EP